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Background: Obesity and physical inactivity are major public health problems. We studied the associations
between measures of adiposity, lean body mass, leisure time physical activity (LTPA), and death in those with and
without chronic kidney disease (CKD).
Methods: Associations between body mass index (BMI), waist circumference (WC), percent body fat, lean body
mass (assessed with Dual-Energy X-ray Absorptiometry[DEXA]), leisure time physical activity (LTPA) and death were
examined using the National Health and Nutrition Examination Surveys (NHANES 1999–2004). All-cause mortality
was ascertained by linkage of NHANES files with the National Death Index.
Results: 9,433 non-CKD participants and 2,153 CKD participants who had fat mass measured using DEXA, BMI, WC,
LTPA and mortality data were included. After adjusting for demographics, comorbid conditions, kidney function
measures, C-Reactive Protein (CRP), and sodium intake there was no significant risk for death noted with higher WC,
fat mass and BMI in those with and without CKD. When examining normal, overweight, and obese groups based
on BMI criteria, being overweight (BMI 25–29.9 kg/m2) was associated with lower risk of death in those without
CKD (Hazard ratio 0.62, 95% CI 0.40, 0.95). Higher lean body mass was associated with lower risk for death in those
without kidney disease but not in the CKD population. There was a significantly higher risk for death among those
who did not meet the minimum LTPA goals compared to those who met or exceeded the recommended activity
levels (>450 MET/min/week) in those with and without CKD (CKD Hazard ratio: 1.36, 95% CI 1.003, 1.85; non-CKD HR
1.65, 95% CI 1.21, 2.26).
Conclusions: In a representative sample of the US population, higher LTPA levels and lean body mass were
associated with lower mortality in those without kidney disease. In CKD, higher LTPA was associated with lower risk
of death. There was no association between adiposity measures and death in those with and without CKD except
for lower mortality associated with overweight among those without CKD. The data suggests the need to develop
programs to facilitate an increase in physical activity in people with and without kidney disease.
Keywords: Obesity, Physical activity, Muscle mass, Kidney disease and deathBackground
Obesity rates have increased in the past few decades
along with an increase in comorbid disease states related
to obesity and health care expenditures [1]. In the gen-
eral population, being overweight (BMI 25–29.9 kg/m2)
and class I obesity (BMI 30–34.9 kg/m2) are associated* Correspondence: navanes@ccf.org
1Department of Nephrology and Hypertension, Glickman Urological and
Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue- Q7, Cleveland, OH
44195, USA
2Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland Clinic,
Cleveland, OH, USA
Full list of author information is available at the end of the article
© 2014 Navaneethan et al.; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.with lower mortality [2]. Some studies have also sug-
gested that measures of abdominal adiposity such as
waist circumference (WC) and waist-to-hip ratio might
be better predictors of adverse outcomes in the general
population [3,4]. Higher BMI is associated with an in-
creased risk for development and progression of kidney
disease [5,6]. However, reports indicate that higher BMI
is associated with lower mortality in those with estab-
lished CKD (reverse epidemiology) [7,8]. Recent popula-
tion based studies have shown that WC rather than BMI
might be a better measure for predicting mortality in
those with CKD [9]. This could be attributed to theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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as differential associations between muscle mass, fat
mass and mortality might exist. However, studies exam-
ining the relationship between body fat, lean body mass
(measured using dual-energy x-ray absorptiometry [DEXA],
CT scan or other modalities) and mortality in those with
CKD are lacking.
Several studies in the general population reported a
lower risk for death among individuals with higher levels
of physical activity [10-13]. Analyses using NHANES III
data (1988–1994) suggested that inactive or insufficient
physical activity levels are associated with lower death
among those with and without kidney disease [14,15].
However, these analysis lacked fat mass and fat free mass
data and whether higher physical activity levels have
similar benefits despite accounting for fat mass and lean
body mass is unknown. We hypothesized that obesity as
measured by - higher percent fat mass, lower lean body
mass and lower leisure time physical activity (LTPA), are
associated with increased mortality in those with and
without CKD. Therefore, we studied the associations be-
tween adiposity measures (BMI, WC and percent body
fat), lean body mass and LTPA with all-cause mortality
among a nationally representative sample of US adults.
Methods
Study population
We examined data from the National Health and Nutri-
tion Examination Survey (NHANES), a nationally repre-
sentative, complex and multistage probability survey of
the US civilian, non-institutionalized population con-
ducted by the National Center for Health Statistics. The
National Centers for Health Statistics Ethics Review
Board approved the study protocol and each participant
provided written informed consent. Participants in
NHANES were interviewed in their homes and under-
went a standardized physical examination in a mobile
examination center. Self-reported information on demo-
graphics, socioeconomic status, health conditions, health
behaviors and routine site of healthcare were obtained
during the interview. The examination component con-
sisted of medical, dental, and physiological measure-
ments, as well as laboratory tests administered by highly
trained medical personnel. The three, 2-year cycles of
the continuous NHANES 1999–2000, 2001–2002, and
2003–2004 were combined for this analysis. 11,586 par-
ticipants who met the following criteria were included:
20 years of age and older who underwent medical exam-
ination, those who were not pregnant, had BMI and WC
measured, had body composition measured or imputed
using DEXA results, had a BMI ≥18.5 kg/m2, had serum
creatinine and albumin/creatinine ratio results, and
those who were not on dialysis and had eGFR ≥15 ml/
min/1.73 m2 (Figure 1).Measures
Kidney disease and comorbidities
Participants without CKD and those with stage 1–4 CKD
were included (Stage 1–2 CKD: those with urinary
albumin-to-creatinine ratio of ≥30–299 mg/g [microalbu-
minuria] and ≥300 mg/g [macroalbuminuria]) with esti-
mated glomerular filtration rate [eGFR] ≥60 ml/min/
1.73 m2, or stage 3–4 CKD: eGFR 15–59 ml/min/1.73 m2).
eGFR was calculated according to the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) equations,
using calibrated creatinine [16]. Serum creatinine levels
were corrected for the 1999–2000 survey as suggested in
the NHANES serum creatinine documentation [17]. Urine
albumin-to-creatinine ratio (UACR) was calculated from
spot urine albumin and creatinine samples. Diabetes was
defined as self-reported if ever told by a doctor that the
participant had “diabetes or borderline diabetes”. Hyper-
cholesterolemia was defined as the presence of total choles-
terol >200 mg/dl and/or use of cholesterol lowering
medications. Liver disease was defined by the answer “yes”
to the question, “Have you ever been told that you had any
liver condition” Hypertension was defined as systolic blood
pressure >140 mm Hg or diastolic blood pressure >90 mm
Hg, or use of antihypertensive medications. Cancer was de-
fined as self-reported by the question “ever told you had
cancer or malignancy.”
Adiposity measures
Trained health technicians used standardized techniques
and equipment to measure height and weight during the
health examination conducted in each survey period.
Waist circumference was measured midway between the
lowest rib and the iliac crest with the participant stand-
ing. We classified male participants with WC >102 cm
and female participants with WC >88 cm as obese [18].
BMI was calculated as weight in kilograms divided by
the measured height in meters squared and we classified
participants as normal if they had BMI 18.5-24.9 kg/m2,
overweight if they had BMI 25–29.9 kg/m2, and obese if
they had a BMI ≥30 kg/m2.
Body fat and lean body mass were measured using
DEXA in NHANES 1999–2004 surveys. DEXA scans were
administered to eligible subjects as part of the medical
examination. Females who were pregnant did not receive
the test. The whole body DEXA scan was acquired using a
Hologic QDR 4500A fan-beam densitometer (Hologic,
Inc., Bedford, Massachusetts) following the manufacturer’s
acquisition procedures. Hologic DOS software version
8.26:a3* was used to acquire all scans; scanning was done
in the fast mode. Because missing and invalid DEXA data
were not missing at random, NHANES analysts per-
formed multiple imputation to fill in missing or invalid
DEXA data and the NHANES website provides 5 multiply
imputed datasets for DEXA analysis [19]. Based on the
NHANES 1999−2000
 Adult not pregnant,
 no ESRD, eGFR>15
 (N=3,795)
NHANES 2001−2002
 Adult not pregnant,
 no ESRD, eGFR>15
(N=4,330)
NHANES 2003−2004
 Adult not pregnant,




Missing BMI or WC or DXA fat
(N=499), BMI<18.5 (N=181), 
 or no mortality data (N=181)
Total Sample






Figure 1 Flow chart of how patients were selected for the analysis.
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and females with >35% body fat were classified as obese.
Lean body mass
Lean body mass excluding bone mineral content data was
obtained from DEXA performed in the NHANES surveys.
Physical activity
Detailed information about leisure time physical activity
(LTPA) over the past 30 days was obtained during the
interview at home. Each LTPA was classified to a MET
score according to the Compendium of Physical Activ-
ities [20]. LTPA was categorized into less than minimum
goal (<450 MET/min/week), meeting the minimum goal
(450 to <750 MET/min/week) and exceeding the recom-
mended goal (>750 MET/min/week) [21].
Mortality data
NHANES Linked Mortality public use files are avail-
able for continuous NHANES periods 1999–2004. The
follow-up time is from survey participation until
December 31, 2006. Mortality status is based on aprobabilistic match between NHANES and NDI death
certificate records.
Statistical analysis
Demographic characteristics, body measurements and
comorbidities between participants with and without
CKD were compared using t-tests for continuous vari-
ables and Rao-Scott chi-square tests for categorical vari-
ables. Cox proportional hazards analyses were used to
assess the association between different body measure-
ments (BMI, WC, percent fat and lean body mass) and
mortality while adjusting for age, gender, race, smoking
status, income, salt intake, log c-reactive protein, cancer,
eGFR and log albumin/creatinine ratio. Covariates were
selected based on previous studies in this area and their
clinical relevance. We assessed adiposity measures as
continuous variables and also classified into categories
as described previously [22]. We tested 2-way interac-
tions between each of the continuous body measure-
ments and age, gender and race in the adjusted models
as these associations might differ based on these factors.
Obesity contributes to the development of diabetes and
Table 1 Characteristics of CKD and non-CKD participants
in NHANES 1999-2004
Variable CKD Non-CKD P-value**
(N = 2153) (N = 9433)
Age, years (mean ± SE) 60.7 (0.7) 43.9 (0.3) <0.001
Male gender, % (SE) 43.1 (1.0) 50.6 (0.4) <0.001
Race, % (SE) 0.004
Non-Hispanic White 71.9 (2.1) 72.4 (1.6)
Non-Hispanic Black 10.8 (1.2) 9.9 (0.9)
Mexican American 5.6 (1.0) 7.6 (0.9)
Other Hispanic 5.8 (1.4) 5.8 (1.1)
Other 5.8 (1.0) 4.2 (0.4)
Smoking, % (SE) 18.7 (1.1) 25.6 (0.8) <0.001
Income, % (SE) <0.001
Missing 11.0 (1.0) 9.0 (0.6)
<20,000 26.3 (1.8) 15.0 (0.8)
20,000-45,000 30.1 (1.4) 26.5 (1.0)
45,000-75,000 18.4 (1.6) 23.4 (0.8)
> = 75,000 14.2 (1.5) 26.1 (1.4)
BMI (mean ± SE) 29.2 (0.3) 28.1 (0.1) <0.001
Waist circumference (cm)
(mean ± SE)
101.1 (0.6) 96.1 (0.3) <0.001
Total fat kg (mean ± SE)* 30.3 (0.4) 28.1 (0.2) <0.001
Total lean mass excluding BMC kg
(mean ± SE)*
49.1 (0.4) 51.2 (0.2) <0.001
Percent body fat (mean ± SE)* 36.7 (0.2) 33.8 (0.1) <0.001
eGFR, ml/min/1.73 m2 (mean ± SE) 72.9 (0.9) 96.8 (0.4) <0.001
UACR (mg/g) (mean ± SE) 154.4 (15.4) 7.1 (0.08) <0.001
C-reactive protein (mg/dL) 0.59 (0.03) 0.39 (0.009) <0.001
Hypertension (SBP >140 or
DBP >90 mm Hg) or use of
antihypertensives
62.4 (1.6) 25.2 (0.8) <0.001
Diabetes 20.4 (1.4) 4.6 (0.2) <0.001
Hyperlipidemia 67.9 (1.5) 52.8 (0.8) <0.001
Liver condition 3.7 (0.5) 3.1 (0.2) 0.07
Cancer,% (SE) 16.1 (1.1) 6.6 (0.3) <0.001
Physical activity,% (SE) <0.001
LTPA <450 METS/week 67.0 (1.7) 53.7 (1.1)
LTPA 450–749.9 METS/week 8.7 (0.8) 9.1 (0.4)
LTPA ≥750 METS/week 24.3 (1.5) 37.2 (1.0)
Sodium intake mg (mean ± SE)*** 3011 (45) 3549 (30) <0.001
*Means and standard errors from survey means on each of the 5 imputations
analyzed using procmianalyze.
**Rao-Scott Chi-square test for categorical variables and t-test for continuous variables.
***Sodium available for 2035 and 8095 CKD and non CKD participants respectively.
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diovascular disease and death. Since diabetes and hyper-
tension are in the causal pathway of associations between
obesity and death, these variables were not adjusted for in
the multivariate models. We evaluated whether adiposity
measures might be associated with mortality in different
ways for those with and without each of those comorbidi-
ties by testing 2-way interaction terms in separate models.
We also ran Cox models with the previously mentioned
factors (except salt intake) plus LTPA below the minimum
recommended level, and tested 2-way interactions be-
tween LTPA and each of the continuous adiposity mea-
sures. 2-way interactions between physical activity and
age, gender and race in the model adjusted for percent fat
were tested. We also evaluated whether LTPA might be
associated with mortality in different ways for those with
and without diabetes and hypertension by testing 2-way
interaction terms in separate models.
All analyses were performed using survey procedures
with SAS version 9.3 for Unix (SAS Institute, Cary, North
Carolina), which account for the sampling design of
NHANES and appropriately weight participants in statis-
tical models. Diet weights were used for analyses including
sodium intake while medical examination weights were
used for all others. All analyses including DEXA results
were run separately on each of the 5 imputed datasets
provided by NHANES and the resulting parameter esti-
mates were combined with SAS proc mianalyze. Graphs
were produced using R version 3.0.1 (The R Foundation
for Statistical Computing, Vienna, Austria).
Results
Participant characteristics
Mean age of the CKD population was 60.7 (0.7) years with
43.1% males, while 50.6% of non-CKD participants were
males with a mean age of 43.9 (0.3) years. A higher propor-
tion of the CKD population had diabetes (20.4% vs. 4.6%),
hypertension (62.4% vs. 52.8%), and hyperlipidemia (67.9%
vs. 52.8%) in comparison to the non-CKD population (all
p-values <0.001, Table 1). Participants with CKD (n = 2,153)
had higher waist circumference (101.6 cm vs. 96.1 cm,
p < 0.001), BMI (29.2 kg/m2 vs. 28.1 kg/m2, p < 0.001) and
fat mass than those without CKD. In addition, a higher pro-
portion of CKD participants were physically inactive
(Table 1). CKD participants had a lower household income
compared to non-CKD participants, with 26% of CKD par-
ticipants earning < $20,000 (vs. 15% of non-CKD popula-
tion) and 14% of participants earning ≥ $75,000 (vs. 26% of
non-CKD population) (Table 1).
Associations between anthropometric measures and death
CKD participants
Of 2,153 subjects with CKD included in our study, 363
died. The average person months of follow-up from thetime of medical examination was 54.0 (SE = 1.1). Among
those with CKD 2,027 participants with 336 deaths had
complete covariate data for the mortality models including
Table 2 Associations between obesity measures (BMI, WC
and body fat) and mortality in CKD and non-CKD
participants of NHANES 1999-2004
CKD Non-CKD
Adjusted HR* Adjusted HR*
(95% CI) (95% CI)
N = 2027 N = 8881
Body mass index
25-29.9 kg/m2 vs. 18.5-24.9 kg/m2 0.84 (0.55, 1.30) 0.62 (0.40, 0.95)
30-34.9 kg/m2 vs. 18.5-24.9 kg/m2 1.03 (0.71, 1.51) 0.84 (0.56, 1.26)
>35 kg/m2 vs. 18.5-24.9 kg/m2 1.29 (0.76, 2.19) 0.62 (0.34, 1.15)
Waist circumference
>102 cm in men and >88 cm in
women (vs. <102 cm in men and
<88 cm in women)
1.04 (0.74, 1.45) 0.87(0.65, 1.16)
Percent body fat**
>25% in men and >35% in women
(vs. <25% in men and <35% in women)
0.87 (0.54, 1.39) 0.70 (0.47, 1.05)
*Adjusted for age, gender, race, smoking, income, log c-reactive protein,
cancer, eGFR log albumin-creatinine ratio and sodium intake.
**Hazard ratios are from 5 imputed datasets obtained by survey phreg, and
combined by mianalyze.
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variables, an increase in BMI, WC, percent body fat or
lean body mass were not significantly associated with
mortality (Figure 2). The categorical analysis also showed
no significant associations between obesity measures (de-
fined by BMI, WC and percent body fat criteria) and mor-
tality (Table 2). We found no significant interaction
between any of the anthropometric measures, lean body
mass and age, gender, race, diabetes or hypertension.
Non-CKD participants
Of 9,433 participants without CKD included in our
study, 303 died during follow-up. The average person
months of follow-up from the time of medical examin-
ation was 57.3 (SE = 1.2). Among those with no CKD
8,881 participants with 288 deaths had complete covari-
ate data for the mortality models including sodium in-
take. When adjusting for age, gender, race, smoking,
house-hold income, c-reactive protein, cancer, eGFR, al-
bumin/creatinine ratio, and sodium intake, an increase
in BMI, WC, or percent body fat were not significantly
associated with mortality Figure 2). In the categorical
analysis, overweight participants had a lower hazard of
death than those with BMI 18.5-24.9 kg/m2 (Hazard ra-
tio [HR] 0.62, 95% CI 0.40, 0.95) but class I and class II
obese participants had no increased risk for death
(Table 2). Obesity defined by high WC and high percent
body fat criteria were also not significantly associated
with mortality (Table 2). On the other hand, each 10 kg
increase higher lean body mass was associated with
lower mortality (HR 0.78, 95% CI 0.62, 0.99) (Figure 2).
We found no significant interaction between any of theFigure 2 Risk for death with higher BMI, WC, percent body fat,
lean body mass and LTPA in CKD and non-CKD participants of
the NHANES 1999–2004 survey.anthropometric measures, lean body mass and age, gen-
der, race, diabetes or hypertension.
Associations between LTPA and mortality
CKD
Among those with CKD 2,145 participants with 363
deaths had complete covariate data for the mortality and
LTPA models. When adjusting for relevant confounding
variables, and percent body fat, LTPA below the recom-
mended level was significantly associated with higher
mortality (HR 1.36, 95% CI 1.003, 1.85). However, while
adjusting for BMI or waist circumference (instead of
percent fat) yielded similar hazard ratios, but these were
not statistically significant (Table 3). In the continuous
analysis, each log unit increase in METS/week was asso-
ciated with lower risk for death (HR 0.97, 95% CI 0.95,
1.00) (Figure 2). We found no significant interaction be-
tween low levels of LTPA and age, gender, race, diabetes
or hypertension.
Non-CKD
Among those with no CKD 9,409 participants with 302
deaths had complete covariate data for the mortality and
LTPA models. When adjusting for relevant confounding
variables and body fat, LTPA below the recommended
level was significantly associated with higher mortality
(Table 3). These results were similar to the model adjusted
for demographics, comorbidities, and either measure of
adiposity (percent body fat, BMI or waist circumference).
We found no significant interaction between LTPA and
Table 3 Associations of leisure time physical activity
(LTPA) with mortality in CKD and non-CKD participants of
NHANES 1999-2004*
CKD Non-CKD
Adjusted HR* Adjusted HR*
(95% CI) (95% CI)
N = 2145 N = 9409
LTPA <450 METS/week vs. ≥450
METS /week (adjusting for Body
Mass Index)
1.34 (0.98, 1.84) 1.65 (1.19, 2.28)
LTPA <450 METS/week vs. ≥450
METS /week (adjusting for percent
body fat assessed by DEXA)
1.36 (1.003, 1.85) 1.65 (1.21, 2.26)
LTPA <450 METS/week vs. ≥450
METS/week (adjusting for Waist
Circumference)
1.33 (0.97, 1.84) 1.64 (1.19, 2.26)
*All models were adjusted for the following variables along with BMI, WC, body
fat, percent body fat, or lean body mass as specified above: age, gender, race,
smoking, income, log c-reactive protein, cancer, eGFR, log albumin-creatinine
ratio; HR-Hazard ratio; CKD-chronic kidney disease; DEXA-dual energy
x-ray absorptiometry.
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a significant interaction between low levels of physical
activity and gender. LTPA <450 METS/min/week was
associated with death in females (HR 2.91, 95% CI 1.60,
5.31) but in males it was not significantly associated
with death ( HR 1.25, 95% CI 0.83, 1.89). In the continu-
ous analysis, each log unit increase in METS/week was
associated with lower risk for death (HR 0.95, 95% CI
0.93, 0.97) (Figure 2).
Discussion
In this nationally representative data from the general
US population, various measures of adiposity including
total and percent body fat were not associated with
death in those with and without kidney disease. Higher
lean body mass was associated with 18% lower risk for
death in those without kidney disease but lean body
mass was not associated with death in CKD. Irrespect-
ive of kidney function, those who did not meet LTPA
goals were at higher risk for death in this cohort. The
associations between adiposity measures seem to be
similar irrespective of age, gender and race, but gender
did modify the associations between LTPA and death
in those without CKD (higher risk in females but not
in males).
In the general population, pooled analysis of several
studies reported that in comparison to normal weight
category, being overweight (BMI 25–29.9 kg/m2) or with
class I obesity (BMI 30.0-34.9 kg/m2) were not associ-
ated with higher mortality [2]. Overall, our results relat-
ing to BMI were similar to previous reports, but we did
not find an association between WC and death as re-
ported in earlier studies [23-26]. These differences could
be attributed to the shorter follow-up data available inNHANES compared to other reports. Absence of associ-
ation between percent and total body fat and mortality
in the general population may be explained by the differ-
ential associations between visceral and subcutaneous
adiposity [27,28]. Body fat distribution is one of the major
determinants of metabolic health, and visceral adiposity
has a stronger correlation with metabolic abnormalities
and cardiovascular disease than subcutaneous adipose tis-
sue [27-29]. Visceral fat is metabolically active and is an
important site for adipokines such as adiponectin and lep-
tin, that can modulate inflammation and insulin resist-
ance, and impart cardiovascular risk [30].
Even though studies have shown a relationship between
obesity and initiation and progression of kidney disease,
studies linking obesity (defined as a BMI ≥30 kg/m2) and
mortality have shown paradoxical results in the CKD
population [7,8,31]. Thus the lack of association between
higher BMI and mortality is not surprising. BMI, a com-
posite measure of muscle, and subcutaneous and visceral
adipose tissue, is widely used to diagnose obesity in clin-
ical practice. Therefore, it has low sensitivity and is likely
to give unreliable results in CKD patients who are often
old, frail, and lack the muscle mass of healthy individuals.
In addition, lower GFR is associated with fluid retention,
which further confounds the utility of anthropometric meas-
urement such as BMI in CKD. Data from the REGARDS
cohort suggested higher mortality rates for those with
higher WC but not with high BMI [9]. However, we did
not observe a higher risk for death with higher WC and
this may be attributed to the small sample size of the
NHANES sample (2153 vs. 5805 in the REGARDS co-
hort). Preliminary data also indicate that visceral fat may
be linked to coronary artery vascular calcification in CKD,
highlighting the need for future studies assessing visceral
fat in the CKD population [32,33].
Higher lean body mass, a reflection of higher muscle
mass, was associated with lower mortality. Few studies
have reported this finding in other cohorts without kid-
ney disease and our findings emphasize the importance
of preserving muscle mass in the aging population [34].
Higher physical activity is associated with higher lean
body mass, and this may be negatively associated with
cardiovascular risk factors including diabetes and hyper-
tension, which could explain the lower risk for death.
Even though studies using urinary creatinine measure-
ments (a proxy for muscle mass) reported higher risk for
death in diabetic nephropathy patients with lower
muscle mass, we did not find such associations with lean
body mass in the CKD population [35]. Future studies
should examine the associations between muscle mass
assessed using MRI or CT, with death, in those with and
without kidney disease.
Physical activity improves insulin sensitivity and endo-
thelial function and lowers inflammatory markers thereby
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physical activity are linked to an overall beneficial impact
on cardiovascular disease and all-cause mortality in the
general population [10-12,38,39]. Greater physical activity
is associated with lower albuminuria in nondiabetic women
and higher levels of physical activity are associated
with a lower risk of decline in kidney function among
adults >65 years after accounting for other comorbid
conditions [40]. In the NHANES III cohort, physical in-
activity was associated with increased mortality in CKD
and non-CKD populations [14,15]. Cumulatively, the data
suggests that physical activity level, a surrogate measure of
their physical fitness, may adversely affect outcomes in
those with and without kidney disease. In addition, there
are recent reports that longer sitting time is associated
with cardiovascular disease and death in the general popu-
lation, however the lack of consistent data collection in
NHANES over the years precluded further analyses [41].
Studies enrolling diabetics and heart failure patients
have reported that both fitness and fatness influence car-
diovascular risk factors [42,43]. A higher physical fitness
levels among those with a higher BMI is associated with
a lower prevalence of cardiovascular risk factors and
mortality, compared to those with normal BMI and
lower fitness level [43-46]. This may also partly explain
the obesity paradox noted in heart failure and diabetic
patients. It is unclear if fitness and fatness are differen-
tially associated with the individual cardiovascular risk
factors and outcomes in CKD. Physical fitness (based on
VO2max measures) was assessed in only a limited num-
ber of NHANES participants precluding further sensitiv-
ity analysis to address this issue.
Strengths of this analysis include the availability of a na-
tionally representative data sample with adequate repre-
sentation of various ethnic groups in the United States,
and availability of longitudinal data to study mortality. In
addition, the use of DEXA to directly determine body
composition provides a measure that has been validated
and correlates highly with other reference methods [47].
However, this analysis is subject to limitations that include
the use of a single UACR measurement in the NHANES
surveys, which may lead to misclassification of CKD,
especially among participants with early-stage CKD. Un-
derstanding the limitations, we used eGFR from single
serum creatinine measurement. Further, the number of par-
ticipants with advanced CKD is relatively small (Additional
file 1: Table S1) and whether these associations exist among
those with advanced kidney disease needs to be con-
firmed in future studies. In addition, availability of long-
term follow-up data might uncover associations that
may have been missed in the current study, as some of
the ill-effects of adipose tissue take many years to mani-
fest. In addition, we did not obtain visceral adiposity
data, which would have helped distinguish the harmfuleffects of visceral adiposity over subcutaneous adiposity.
When we adjusted for diabetes and hypertension, the
results remained similar for the non-CKD population,
but lost statistical significance for those with CKD (HR
1.32, 95% 0.99, 1.76). These factors were not adjusted
for in the multivariate models as lie in the causal path-
way between obesity, low physical activity and death in
CKD population [48].Conclusion
In summary, physical activity, but not adipose tissue
measures, is associated with mortality in those with and
without CKD in the US population as represented by
NHANES. Higher lean body mass, a surrogate of higher
muscle mass, is associated with lower risk for death in
those without kidney disease. These data highlight the
need to find ways to improve physical activity to posi-
tively impact health outcomes in those with and without
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